News

Advances in Sub-Acute Stroke Motor Recovery

Pharmacological support in early rehabilitation - The CARS (Cerebrolysin® and Recovery After Stroke) Trial results.
read more

CARS trial - rehabilitation after stroke with Cerebrolysin®

Neurologisch – a well-known Austrian journal – reviewed the CARS results.
read more
1 … 65 66 67 68
03.04.2025

Cerebrolysin® as an Adjuvant Therapy After Mechanical Thrombectomy in Cardioembolic Stroke

Does Cerebrolysin® increase the safety and efficacy after mechanical thrombectomy?
Read more
1 … 34
Go to Archive

Congresses

11th European Stroke Organisation Conference

Helsinki, Finland
21 - 23 May 2025
GO TO EVENT

17th World Stroke Congress

Barcelona, Spain
22 - 25 October 2025
GO TO EVENT

Notice to U.S. Visitors

Please be advised that Cerebrolysin is not registered with the U.S. Food and Drug Administration (FDA) and is not approved for sale or distribution in the United States.

Cerebrolysin is a prescription medication for use under the supervision of an authorized health care professional. For any medical inquiries, please consult with a healthcare professional.